🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
Other Combinations Product Type
67% Evidence Coverage

Supplement Facts — Evidence Check

5 IU (17% DV)
✅ Within RDA (0.2× RDA of 15 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 3.35mg UL 1000mg
200 mg
📊 Market median: 100.0mg (283 products) 📚 142 studies (Tier A: 1, B: 64)
This product: 200mg UL 1200mg
📊 Market median: 20.0mg (9 products) 📚 5 studies — no high-quality reviews
This product: 20mg

Other Ingredients

Softgel capsule Rice Bran Oil yellow Beeswax Soy Lecithin medium chain triglycerides Soybean Silica

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (81% of products) Nutrient (56% of products) Qualified Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested Use: 1 softgel per day or as directed by a health care professional.

⚠️ Warnings & Precautions

Sealed for your protection. Do not use if seal is broken.

🧪 Formulation Notes

Contains no artificial preservatives or sweeteners; no corn, dairy, gluten, starch, wheat or yeast.

Additional Information

PQQ, considered a novel cofactor with antioxidant and B vitamin-like activity, enhances the biosynthesis of nerve growth factor (NGF), a key protein involved in the growth and survival of neurons.* PQQ and CoQ10 work together to promote antioxidant and mitochondrial health, providing multifunctional support for cardiovascular health and cognitive function.*

For freshness, store in a cool, dry place.

PURE POTENT TRUSTED TESTED

LOT205227 EXPMR2013 Recyclable container. PRODUCT OF CANADA

Advanced Mitochondrial & Nerve Growth Factor Support*

R0

{recycle}

Product Details

UPC / SKU 6 29022 09271 0
DSLD Entry Date 2013-04-25
Product Type Other Combinations
Form Softgel Capsule
DSLD ID 20853
Data Updated 2026-04-11

Research Evidence

253 Research Sources
55 Avg Quality Score
128 Meta Analysis
52 Systematic Review
41 Rct
24 Clinical Trial
3 Regulatory Source
1 Narrative Review
1 Other
1 Guideline
1 Openfda Safety
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Systematic Review The Cochrane database of systematic reviews 2017
A Vitamin E for Alzheimer's disease and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2008
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2012
A Exercise for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2017
A Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis
Meta Analysis Nutritional neuroscience 2021
A Effect of vitamin E supplementation in rheumatoid arthritis: a systematic review and meta-analysis
Meta Analysis European journal of clinical nutrition 2023
A Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Rct JAMA 2011
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2017
B Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2022
View all evidence for Vitamin E →

Compare Similar Products

View all Vitamin E products →